Dzenete Kadrija
Trento, 38122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC.
Journal: Future oncology (London, England)
Published: April 28, 2025
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide.
Journal: Clinical genitourinary cancer
Published: June 25, 2024
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: May 10, 2024
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study.
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 18, 2024
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Journal: International journal of molecular sciences
Published: November 12, 2020
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done.
Journal: Translational lung cancer research
Published: October 20, 2020
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 22, 2020
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation.
Journal: Breast (Edinburgh, Scotland)
Published: January 25, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026